Evaxion

Evaxion is an AI-Immunology™ platform company decoding the human immune system to discover and develop novel immunotherapies for cancer and infectious diseases.

We have developed our AI-immunology core technology to deeply understand the biological processes relevant for engaging the immune system so we can harness its powers through novel immunotherapies. Our scalable AI-Immunology™ core technology enables broad applicability across diseases with immunological components. With deep insights into the biological processes of the immune system, we bridge technology, engineering expertise and drug development know-how to bring novel immunotherapies to patients.